From what I can see in the announcement, I don't see it as an obituary for POH. Does even appear as if there could be a window left open for PO in fact. POH has stated both a payout option and a licence option and I guess anything we discuss will be speculation anyway.
However, can I put something out there to those with an intimate knowledge of the company.
1) What is the possibility that POH would part with the licence if MYLAN agrees to not put a financial sanction on POH for costs? I ask in the full knowledge that POH valued the damages at $300mil but is currently getting nothing from MYLAN for that licence. I also must note that costs (say $15mil) would be small bikkies for a company the size of MYLAN. If POH took that road, it may give itself another 12 months to investigate other avenues.
2) Even more out there perhaps, would MYLAN offer POH some sort of merger (a gentle term) meaning it keeps the licence and maybe picks up POH for say $10mil which would be a bargain price for the IP at least and get rid of a potential future competitor.
It makes little sense for MYLAN to crush POH out of existence when POH could easily sell its assets - IP and would include the licence rights to a third party before going under. Mylan would not even recover its costs and would have the assets out there working for someone else.
- Forums
- ASX - By Stock
- POH
- Ann: Trading Halt
Ann: Trading Halt, page-15
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add POH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.0¢ |
Change
0.000(0.00%) |
Mkt cap ! n/a |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
POH (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online